HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital

dc.contributor.author	Lule, G. N.
dc.contributor.author	Okoth, F.
dc.contributor.author	Ogutu, E. O.
dc.contributor.author	Mwai, S. J.
dc.date.accessioned	2013-05-15T14:48:27Z
dc.date.available	2013-05-15T14:48:27Z
dc.date.issued	1989-05
dc.identifier.citation	East Afr Med J.	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/2791927
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/23350
dc.description.abstract	In an exercise to study the immunogenicity and reactogenicity of the Engerix B vaccine, 160 medical students were screened for Hepatitis B Markers (HBsAg, HBsAb and HBcAb) with a view to vaccinating those that were negative. 18% were HBsAg + ve, 33% were HBsAb + ve and 38% were positive for the HBcAb. These figures were extremely high and obviated the need to vaccinate the students as they begin their clinical years	en
dc.language.iso	en	en
dc.relation.ispartofseries	Vol. 66(5):315-8.(1989);
dc.title	HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital	en
dc.type	Article	en
local.publisher	School of Medicine, University of Nairobi	en